Supplementary Tables S1-S7 from Detection of Brain Cancer Using Genome-wide Cell-free DNA Fragmentomes

Supplementary Table S1. Clinical information, sequencing statistics, and ARTEMIS-DELFI scores for cfDNA analyses in Discovery cohort. Supplementary Table S2. Clinical information, sequencing statistics, and ARTEMIS-DELFI scores for cfDNA analyses in Validation cohort. Supplementary Table S3. Summary of mutations detected by plasma-based targeted sequencing panel. Supplementary Table S4. Correlation of TF expression between GBM and other tumor types. Supplementary Table S5. Summary of complete blood count for patients with gliomas or non-neoplastic neurological conditions. Supplementary Table S6. Summary of ChIP-Seq peaks used in DECIFER analysis. Supplementary Table S7. Correlation of TFBS relative coverage differences with expression differences between tumor/cell types and whole blood.